Dermata Therapeutics, Inc. Profile Avatar - Palmy Investing

Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate…

Biotechnology
US, San Diego [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of DRMA's Analysis
CIK: 1853816 CUSIP: 249845108 ISIN: US2498453065 LEI: - UEI: -
Secondary Listings
DRMA has no secondary listings inside our databases.